Investigating the structure of the DENV-2 envelope protein in complex with the EDE2 B7 antibody using metadynamics simulations
Dengue is a serious disease with a particularly high transmission rate in the tropics. There is currently only one WHO-approved vaccine, but it has limitations. A key therapeutic target on the dengue virus is the envelope glycoprotein (E protein) dimer which coats the outer surface. A new type of...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/69194 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Dengue is a serious disease with a particularly high transmission rate in the tropics.
There is currently only one WHO-approved vaccine, but it has limitations. A key
therapeutic target on the dengue virus is the envelope glycoprotein (E protein) dimer
which coats the outer surface. A new type of antibody has been discovered that
binds to the E-dimer dependent epitope (EDE) which involves both monomers within
the same epitope. However, the exact mechanism of action is unknown. It is possible
that it locks the monomers to prevent subsequent acid-induced dissociation and
trimerisation that are required for viral fusion with the cell. A computer simulation
study was designed to investigate the mechanism of the EDE2 B7 antibody in
complex with the soluble ectodomain of the E dimer. Metadynamics was used in
molecular dynamics simulations of the E protein dimer with and without the antibody
in neutral and acidic conditions. Bias potentials were applied on the collective
variables of inter-dimer contacts, inter-dimer distance and root-mean square
deviation during the simulation to enhance conformational sampling. Acidic
conditions were found to destabilise the dimer while the presence of the antibody
maintained the binding between the monomers, thus highlighting the therapeutic
potential of this antibody. |
---|